Anesthetic Management of Postpartum Hemorrhage

DOI

10.2991/ahsr.k.210723.024How to use a DOI?

Keywords

anesthetic managements, covid-19, obstetric anesthesia, postpartum hemorrhage

Abstract

Postpartum haemorrhage (PPH) is a leading cause of maternal morbidity and mortality in the world. It requires a higher level of standard care. Peripartum haemorrhage is bleeding that occurs during pregnancy (antepartum), at birth (intrapartum) and after birth (postpartum). Management of postpartum haemorrhage should be done with multidisciplinary approach including determining the cause of PPH, close observation of vital signs, and intravenous access with a minimum of one large bore. Hemodynamic condition should be stabilized first. In 2020, WHO officially stated COVID-19 as a pandemic which requires the use of suitable Personal Protective Equipment (PPE) depending on the condition. When the diagnosis of PPH is made, prompt resuscitation with administration of crystalloid, colloid, oxygen therapy, and protection against hypothermia, obtaining initial blood sample. Pharmacological therapy includes oxytocin IV or IM, sulproston and carboprost as the effective and recommended drugs. Blood transfusion is required.

Copyright

© 2021, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Djoni Kusumah Himsani Pohan
PY  - 2021
DA  - 2021/07/24
TI  - Anesthetic Management of Postpartum Hemorrhage
BT  - Proceedings of the 12th Annual Scientific Meeting, Medical Faculty, Universitas Jenderal Achmad Yani, International Symposium on "Emergency Preparedness and Disaster Response during COVID 19 Pandemic" (ASMC 2021)
PB  - Atlantis Press
SP  - 99
EP  - 102
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.210723.024
DO  - 10.2991/ahsr.k.210723.024
ID  - Pohan2021
ER  -